Far Eastern Memorial Hospital: Urinary Bladder, Overactive trials
The registry lists 11 Urinary Bladder, Overactive studies with Far Eastern Memorial Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 3 2Phase 4 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve StimulationNot yet recruitingNCT07744620Not applicable
- The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingNCT07114640Phase 3
- Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled StudyRecruitingNCT05946902Phase 4
- HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial StiffnessRecruitingNCT05280028
- Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinRecruitingNCT04023253Phase 3
- Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder SyndromeStatus unknownNCT05040984
- Efficacy of Biofeedback PFMT and Medication in Women With Overactive BladderCompletedNCT04477265Not applicable
- Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder SyndromeWithdrawnNCT03695822Phase 4
- Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime DosingStatus unknownNCT03251300Phase 4
- Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.CompletedNCT01884753
- Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime DosingCompletedNCT01819168